ATM and ataxia telangiectasia: Novel non-aminoglycosides with readthrough properties have been identified, by using an ELISA based assay, in a screening of a library of 34,000 small compounds for searching for those capable of suppressing nonsense mutations in the ATM gene that causes ataxia telangiectasia (AT) [79].